Pre-treatment considerations should include: Disease activity assessment : GLP-1 agonists should ideally be initiated when Crohn's disease is in remission or well-controlled, as distinguishing medication side effects from disease flare becomes challenging during active inflammation Nutritional status evaluation : Patients with Crohn's disease may already have compromised nutritional status
De Laet C, Kanis J, Odn A, Johanson H, Johnell O, Delmas P, et al
Social Media Gestiamo i tuoi social media con strategie e contenuti mirati per aumentare visibilit e autorevolezza del brand
Yang Y, Hahn JH, Kim MS, Jo M, Lee YP, Kim H
Zhou Z, Ren B, Li J, Zhou X, Xu X, Zhou Y